Haleon plc (LON:HLN) Plans Dividend Increase – GBX 4.60 Per Share

Haleon plc (LON:HLN) announced a dividend on Thursday, February 27th, DividendData.Co.Uk reports. Investors of record on Thursday, April 24th will be given a dividend of GBX 4.60 ($0.06) per share on Thursday, June 5th. This represents a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, April 24th. This is a 130.0% increase from Haleon’s previous dividend of $2.00. The official announcement can be accessed at this link.

Haleon Price Performance

Shares of LON HLN opened at GBX 381.70 ($5.11) on Tuesday. Haleon has a fifty-two week low of GBX 319.84 ($4.28) and a fifty-two week high of GBX 417.70 ($5.59). The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84. The company has a market cap of £34.45 billion, a PE ratio of 32.10, a P/E/G ratio of 1.49 and a beta of 0.19. The business has a 50-day simple moving average of GBX 387.21 and a two-hundred day simple moving average of GBX 379.76.

Haleon (LON:HLN) last posted its quarterly earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share (EPS) for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. As a group, equities analysts expect that Haleon will post 19.5033282 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Berenberg Bank boosted their price target on Haleon from GBX 456 ($6.10) to GBX 457 ($6.12) and gave the company a “buy” rating in a research note on Friday, February 28th.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.